Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
€ 121,00 0.00 (0.00%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFulton Bank, N.a.
Latest Disclosed Ownership5,834 shares
Latest Disclosed Value $ 891,143
Fulton Bank, N.a. reports 11.59% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 24, 2026 - Fulton Bank, N.a. filed a 13F-HR form disclosing ownership of 5,834 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $749,669 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 6,599 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -11.59% during the quarter. The current value of the position is $705,914 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 5,834 -765 -11.59 891 -1.98 0.0175
2026-01-08 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,599 1,213 22.52 910 31.74 0.0314
2025-10-21 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 5,386 898 20.01 691 27.07 0.0241
2025-07-10 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,488 -1,947 -30.26 543 -24.27 0.0201
2025-04-09 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,435 -1,342 -17.26 717 -5.16 0.0290
2025-01-08 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,777 1,281 19.72 757 1.20 0.0292
2024-10-07 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,496 267 4.29 747 12.67 0.0285
2024-07-09 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,229 -857 -12.09 663 -3.21 0.0268
2024-04-10 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,086 -1,269 -15.19 685 -18.74 0.0281
2024-01-24 2023-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 8,355 804 10.65 844 9.62 0.0380
2024-01-04 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,355 804 844 0.0205
2023-10-04 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,551 1,016 15.55 769 16.69 0.0383
2023-07-06 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,535 424 6.94 659 17.26 0.0323
2023-04-06 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,111 -876 -12.54 562 -11.36 0.0295
2023-01-05 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,987 -360 -4.90 1 -100.00 0.0357
2022-10-04 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,347 -3,661 -33.26 559 -39.96 0.0334
2022-07-07 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,008 1,633 17.42 931 13.26 0.0519
2022-04-05 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,375 -550 -5.54 822 -5.30 0.0385
2022-01-05 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 9,925 -4,257 -30.02 868 -25.17 0.0381
2021-10-05 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 14,182 -1,728 -10.86 1,160 -20.11 0.0540
2021-07-06 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 15,910 2,437 18.09 1,452 26.04 0.0677
2021-04-05 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,473 3,160 30.64 1,152 18.28 0.0581
2021-01-07 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 10,313 1,068 11.55 974 21.14 0.0525
2020-10-06 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,245 -1,488 -13.86 804 -14.19 0.0494
2020-07-06 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,733 4,814 81.33 937 92.01 0.0618
2020-04-03 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,919 2,733 85.78 488 61.59 0.0389
2020-01-24 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,186 270 9.26 302 18.90 0.0188
2019-10-03 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,916 623 27.17 254 20.95 0.0172
2019-07-03 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,293 -2,075 -47.50 210 -50.00 0.0142
2019-04-03 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,368 -691 -13.66 420 -3.23 0.0294
2019-01-03 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,059 1,510 42.55 434 41.83 0.0346
2018-10-03 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,549 -454 -11.34 306 1.32 0.0201
2018-07-10 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 4,003 4,003 302 0.0209
2017-10-04 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -11,337 -100.00 0 -100.00
2017-07-11 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 11,337 -11,560 -50.49 946 -44.39 0.0735
2017-04-06 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 22,897 272 1.20 1,701 3.22 0.1398
2017-01-05 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 22,625 22,625 0.00 1,648 0.1459
2016-07-06 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 0 -2,983 -100.00 0 -100.00
2016-04-07 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,983 -183 -5.78 216 -20.88 0.0220
2016-01-06 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,166 0 0.00 273 -6.19 0.0283
2015-10-05 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,166 0 0.00 291 -6.73 0.0328
2015-07-06 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,166 -34 -1.06 312 -0.95 0.0324
2015-04-23 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,200 -820 -20.40 315 -15.55 0.0332
2015-01-07 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,020 75 1.90 373 0.27 0.0413
2014-10-27 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,945 247 6.68 372 11.04 0.0423
2014-07-02 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,698 -84 -2.22 335 4.36 0.0373
2014-04-03 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,782 -633 -14.34 321 -9.58 0.0369
2014-01-08 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,415 -233 -5.01 355 -0.56 0.0416
2013-10-03 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 4,648 -205 -4.22 357 4.08 0.0419
2013-09-26 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 4,853 4,853 343 0.0428
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.